🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to evaluate the effect of arginine/lysine solu...
Status
Completed
Location
Istituto Europeo di Oncologia
Start Date
2021-01-25
Trial ID
NCT04524442
Treatments Being Tested
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2014-12
Trial ID
NCT01860742
Treatments Being Tested
This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-08-27
Trial ID
NCT03457948
This is a randomized phase II non-comparative study. Patients with gastroen...
Status
Terminated
Location
Irst Irccs
Start Date
2013-12
Trial ID
NCT02489604
Treatments Being Tested
Background: A neuroendocrine tumor is a rare type of tumor. It comes from ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-10-03
Trial ID
NCT04086485
Treatments Being Tested
Neuroendocrine tumours (NETs) are rare, slow growing, and diagnosis is ofte...
Status
Suspended
Location
Cross Cancer Institute
Start Date
2014-04-29
Trial ID
NCT01876771
Treatments Being Tested
Peptide receptor radionuclide therapy (PRRT) with \[177Lu\]Lu-\[DOTA0,Tyr3\...
Status
Terminated
Location
Multiple Locations
Start Date
2007-03-01
Trial ID
NCT07012330
Treatments Being Tested
This phase 1 dose-escalation study is designed to evaluate the safety and t...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2021-12-08
Trial ID
NCT05053854
Treatments Being Tested
The purpose of the study is to evaluate efficacy and safety of Peptide Rece...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-01-31
Trial ID
NCT03422029
Treatments Being Tested
The purpose of this study is to learn about the feasibility and safety of u...
Status
Active Not Recruiting
Location
Stanford Cancer Institute Palo Alto
Start Date
2021-03-17
Trial ID
NCT04609592
Treatments Being Tested